865625-56-5
865625-56-5
Chemical Structure
Ladarixin sodium
Synonym(s): DF 2156A
- CAS No.: 865625-56-5
- Formula:C11H11F3NNaO6S2
- Molecular Weight:397.32
IUPAC Name: sodium (R)-(methylsulfonyl)(2-(4-(((trifluoromethyl)sulfonyl)oxy)phenyl)propanoyl)amide
InChIKey: QICAUCDBOAKDNS-OGFXRTJISA-M
SMILES: O=S(C(F)(F)F)(OC1=CC=C([C@@H](C)C([N-]S(=O)(C)=O)=O)C=C1)=O.[Na+]
Biological Activity:
Ladarixin sodium (DF 2156A) is an orally active, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist. Ladarixin sodium can be used for the research of COPD and asthma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ladarixin sodium | 99.84% | Ladarixin sodium (DF 2156A) is an orally active, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist. Ladarixin sodium can be used for the research of COPD and asthma. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
